Omeros reported $403.72M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Adma Biologics USD 191.64M 1.2M Sep/2026
Alnylam Pharmaceuticals USD 2.11B 358.58M Sep/2026
BioMarin Pharmaceutical USD 3.51B 12.96M Sep/2026
Cytokinetics USD 244.33M 3.87M Sep/2026
Gilead Sciences USD 23.82B 17M Sep/2026
Heron Therapeutics USD 140.64M 975K Dec/2025
Immunic USD 0 0 Jun/2024
Insmed USD 544.86M 1.35M Sep/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
MacroGenics USD 163.16M 94.44M Jun/2026
Omeros USD 403.72M 27.2M Jun/2024
Pfizer USD 60B 498M Sep/2026
Rockwell Medical USD 8.65M 89K Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 699.39M 148.23M Sep/2026
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 3.5B 3.39B Sep/2026